New blood test may help protect kids from post-transplant infection
NCT ID NCT03924219
First seen Apr 06, 2026 · Last updated Jun 23, 2026 · Updated 18 times
Summary
This study looked at whether a blood test that measures immune response to CMV can predict infection risk in children who have received a heart, kidney, or liver transplant. Researchers tested blood samples from 161 children within the first year after transplant. The goal is to find immune response levels that indicate protection, which could help doctors decide how long to give antiviral drugs or how often to monitor for infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Albert Einstein College of Medicine/Children's Hospital at Montefiore
New York, New York, 10467, United States
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Duke University Medical Center/Duke Children's Hosptial
Durham, North Carolina, 27710, United States
-
Emory University Medical Center/Children's Hospital of Atlanta
Atlanta, Georgia, 30322, United States
-
Northwestern University Medical Center/Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
Stanford University Medical Center/Lucile Packard Children's Hospital Stanford
Stanford, California, 94305, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Pittsburgh Medical Center/Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CMV T cell Immunity Assay (blood test)
What this could lead to
If successful, this test could help doctors personalize antiviral treatment for children after transplant, reducing unnecessary medication and preventing infections.
What could go wrong
This is an observational study, not a treatment trial. The test may not accurately predict infection risk in all children, and results may not change current care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.